Cellectis (ALCLS) — Cash Flow Reinvestment Rate

Latest as of June 2024: 2.06x

Cellectis (ALCLS) has a Cash Flow Reinvestment Rate of 2.06x as of June 2024, reinvesting €107.47 Million (capex €1.04 Million plus investments €-106.43 Million) from operating cash flow of €52.18 Million. Check ALCLS cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

2.06x
(Capex + Investments) / Operating CF

Total Reinvested

€107.47 Million
Capex + Investments

Operating Cash Flow

€52.18 Million
EUR

Capital Expenditures

€1.04 Million
EUR

Cellectis Cash Flow Reinvestment Rate (2005–2024)

Historical reinvestment intensity for Cellectis across 5 annual periods. Explore Cellectis (ALCLS) long-term investment share to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Cellectis (2005–2024)

Year-by-year capital reinvestment analysis for Cellectis. For live market cap and broader valuation context, see ALCLS market cap overview.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2024 4.64x €106.65 Million €22.99 Million €3.84 Million ▲ +263.4%
2015 1.28x €4.52 Million €3.54 Million €4.25 Million ▲ +3184.1%
2014 0.04x €1.97 Million €50.74 Million €430.47K ▼ -91.3%
2008 0.44x €790.71K €1.78 Million €790.71K ▼ -50.8%
2005 0.90x €353.00K €391.00K €353.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow